Concepedia

Tithi Ghosh

TG

Statistics

Publications

17

Citations

555

H-Index

15

Active since

2013

Affiliations

Chittaranjan National Cancer Institute(Current)

Bose Institute

City of Hope

University of Utah

Translational Genomics Research Institute

Tithi Ghosh is an author at Chittaranjan National Cancer Institute specializing in oncology, immunology, and medicine.

ORCID

Publications per year

2013–2022

17

Publications

17

The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer

Raffaella Soldi, Tithi Ghosh, Alexis Weston et al. · PLoS ONE · 2020 · 82 citations · Full text

, , +16

Tumor-Derived Vascular Pericytes Anergize Th Cells

Anamika Bose, Subhasis Barik, Saptak Banerjee et al. · The Journal of Immunology · 2013 · 74 citations

, , +17

Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells

Soumyabrata Roy, Kai Lǚ, Mukti Kant Nayak et al. · Journal of Biological Chemistry · 2016 · 54 citations · Full text

, , +17

Neem Leaf Glycoprotein Prophylaxis Transduces Immune Dependent Stop Signal for Tumor Angiogenic Switch within Tumor Microenvironment

Saptak Banerjee, Tithi Ghosh, Subhasis Barik et al. · PLoS ONE · 2014 · 44 citations · Full text

, , +17

RGS5–TGFβ–Smad2/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth

Shayani Dasgupta, Tithi Ghosh, Jesmita Dhar et al. · Cell Death and Differentiation · 2021 · 44 citations · Full text

, , +15

1–5 of 17